These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

316 related items for PubMed ID: 25878292

  • 1. Tau-dependent Kv4.2 depletion and dendritic hyperexcitability in a mouse model of Alzheimer's disease.
    Hall AM, Throesch BT, Buckingham SC, Markwardt SJ, Peng Y, Wang Q, Hoffman DA, Roberson ED.
    J Neurosci; 2015 Apr 15; 35(15):6221-30. PubMed ID: 25878292
    [Abstract] [Full Text] [Related]

  • 2. Reduction of Dendritic Inhibition in CA1 Pyramidal Neurons in Amyloidosis Models of Early Alzheimer's Disease.
    Ruiter M, Herstel LJ, Wierenga CJ.
    J Alzheimers Dis; 2020 Apr 15; 78(3):951-964. PubMed ID: 33074225
    [Abstract] [Full Text] [Related]

  • 3. Limiting RyR2 Open Time Prevents Alzheimer's Disease-Related Neuronal Hyperactivity and Memory Loss but Not β-Amyloid Accumulation.
    Yao J, Sun B, Institoris A, Zhan X, Guo W, Song Z, Liu Y, Hiess F, Boyce AKJ, Ni M, Wang R, Ter Keurs H, Back TG, Fill M, Thompson RJ, Turner RW, Gordon GR, Chen SRW.
    Cell Rep; 2020 Sep 22; 32(12):108169. PubMed ID: 32966798
    [Abstract] [Full Text] [Related]

  • 4. Dendritic structural degeneration is functionally linked to cellular hyperexcitability in a mouse model of Alzheimer's disease.
    Šišková Z, Justus D, Kaneko H, Friedrichs D, Henneberg N, Beutel T, Pitsch J, Schoch S, Becker A, von der Kammer H, Remy S.
    Neuron; 2014 Dec 03; 84(5):1023-33. PubMed ID: 25456500
    [Abstract] [Full Text] [Related]

  • 5. Deletion of Kv4.2 gene eliminates dendritic A-type K+ current and enhances induction of long-term potentiation in hippocampal CA1 pyramidal neurons.
    Chen X, Yuan LL, Zhao C, Birnbaum SG, Frick A, Jung WE, Schwarz TL, Sweatt JD, Johnston D.
    J Neurosci; 2006 Nov 22; 26(47):12143-51. PubMed ID: 17122039
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Synergistic effects of amyloid-beta and wild-type human tau on dendritic spine loss in a floxed double transgenic model of Alzheimer's disease.
    Chabrier MA, Cheng D, Castello NA, Green KN, LaFerla FM.
    Neurobiol Dis; 2014 Apr 22; 64():107-17. PubMed ID: 24440055
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Chemogenetic attenuation of neuronal activity in the entorhinal cortex reduces Aβ and tau pathology in the hippocampus.
    Rodriguez GA, Barrett GM, Duff KE, Hussaini SA.
    PLoS Biol; 2020 Aug 22; 18(8):e3000851. PubMed ID: 32822389
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Glucocorticoid receptors modulate dendritic spine plasticity and microglia activity in an animal model of Alzheimer's disease.
    Pedrazzoli M, Losurdo M, Paolone G, Medelin M, Jaupaj L, Cisterna B, Slanzi A, Malatesta M, Coco S, Buffelli M.
    Neurobiol Dis; 2019 Dec 22; 132():104568. PubMed ID: 31394203
    [Abstract] [Full Text] [Related]

  • 13. Regulation of dendritic excitability by activity-dependent trafficking of the A-type K+ channel subunit Kv4.2 in hippocampal neurons.
    Kim J, Jung SC, Clemens AM, Petralia RS, Hoffman DA.
    Neuron; 2007 Jun 21; 54(6):933-47. PubMed ID: 17582333
    [Abstract] [Full Text] [Related]

  • 14. Suppression of a neocortical potassium channel activity by intracellular amyloid-β and its rescue with Homer1a.
    Yamamoto K, Ueta Y, Wang L, Yamamoto R, Inoue N, Inokuchi K, Aiba A, Yonekura H, Kato N.
    J Neurosci; 2011 Aug 03; 31(31):11100-9. PubMed ID: 21813671
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Intrinsic excitability changes induced by acute treatment of hippocampal CA1 pyramidal neurons with exogenous amyloid β peptide.
    Tamagnini F, Scullion S, Brown JT, Randall AD.
    Hippocampus; 2015 Jul 03; 25(7):786-97. PubMed ID: 25515596
    [Abstract] [Full Text] [Related]

  • 17. The KATP channel activator diazoxide ameliorates amyloid-β and tau pathologies and improves memory in the 3xTgAD mouse model of Alzheimer's disease.
    Liu D, Pitta M, Lee JH, Ray B, Lahiri DK, Furukawa K, Mughal M, Jiang H, Villarreal J, Cutler RG, Greig NH, Mattson MP.
    J Alzheimers Dis; 2010 Jul 03; 22(2):443-57. PubMed ID: 20847430
    [Abstract] [Full Text] [Related]

  • 18. NMDA-mediated Ca(2+) influx drives aberrant ryanodine receptor activation in dendrites of young Alzheimer's disease mice.
    Goussakov I, Miller MB, Stutzmann GE.
    J Neurosci; 2010 Sep 08; 30(36):12128-37. PubMed ID: 20826675
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.